Gmo Emerging Markets Fund Current Valuation
| GMEMX Fund | USD 24.32 0.10 0.41% |
Valuation analysis of Gmo Emerging Markets helps investors to measure Gmo Emerging's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Gmo Emerging's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Gmo Emerging Markets retains a regular Real Value of $24.54 per share. The prevalent price of the fund is $24.32. We determine the value of Gmo Emerging Markets from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.
Since Gmo Emerging is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Gmo Mutual Fund. However, Gmo Emerging's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 24.32 | Real 24.54 | Hype 24.32 | Naive 24.04 |
The intrinsic value of Gmo Emerging's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Gmo Emerging's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Gmo Emerging Markets helps investors to forecast how Gmo mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Gmo Emerging more accurately as focusing exclusively on Gmo Emerging's fundamentals will not take into account other important factors: Gmo Emerging Markets Mutual Fund Current Valuation Analysis
Gmo Emerging's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Gmo Emerging Markets has a Current Valuation of 0.0. This indicator is about the same for the GMO average (which is currently at 0.0) family and about the same as Diversified Emerging Mkts (which currently averages 0.0) category. This indicator is about the same for all United States funds average (which is currently at 0.0).
Gmo Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gmo Emerging's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the mutual funds which would be a good addition to a portfolio. Peer analysis of Gmo Emerging could also be used in its relative valuation, which is a method of valuing Gmo Emerging by comparing valuation metrics of similar companies.Gmo Emerging is currently under evaluation in current valuation among similar funds.
Fund Asset Allocation for Gmo Emerging
The fund invests 99.89% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.Asset allocation divides Gmo Emerging's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Gmo Fundamentals
| Price To Earning | 9.99 X | |||
| Price To Book | 1.23 X | |||
| Price To Sales | 0.83 X | |||
| Total Asset | 2.81 B | |||
| Annual Yield | 0.03 % | |||
| Year To Date Return | 5.32 % | |||
| One Year Return | 12.90 % | |||
| Three Year Return | (5.48) % | |||
| Five Year Return | (0.62) % | |||
| Ten Year Return | 2.34 % | |||
| Net Asset | 3.78 B | |||
| Last Dividend Paid | 0.09 | |||
| Cash Position Weight | (1.79) % | |||
| Equity Positions Weight | 99.89 % |
About Gmo Emerging Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gmo Emerging Markets's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gmo Emerging using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gmo Emerging Markets based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Gmo Mutual Fund
Gmo Emerging financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Emerging security.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |